Clinical Research

Evaluation of 4% Mangosteen (MG) Gel as a Local Drug Delivery in adjunct to Scaling and Root planing on Clinical Parameters and GCF MMP-9 levels in Chronic Periodontitis Patients - A Split Mouth Randomized Controlled Trial

Volume: 7 Number: 3 December 26, 2023
EN TR

Evaluation of 4% Mangosteen (MG) Gel as a Local Drug Delivery in adjunct to Scaling and Root planing on Clinical Parameters and GCF MMP-9 levels in Chronic Periodontitis Patients - A Split Mouth Randomized Controlled Trial

Abstract

Objective: The current study was conducted to assess the efficacy of 4% Mangosteen (MG) gel in adjunct to Scaling and root planing (SRP) on clinical parameters and Gingival Crevicular Fluid (GCF) matrix metalloproteinase 9 (MMP-9) levels in the management of patients with chronic periodontitis. Methodology: This double blinded, randomized, placebo-controlled, split mouth, clinico-biochemical study was carried out on 13 patients (26 experimental sites) with Stage II and Grade B periodontitis. Following subgingival SRP, the 13 control sites were treated with LDD of placebo gel and the 13 test sites with 4% MG gel. Clinical parameters including plaque index (PI), gingival bleeding index (GBI), probing depth (PD) and relative attachment level (RAL) were recorded and GCF was collected from all the experimental sites for MMP-9 analysis, using Enzyme Linked Immunosorbent Assay (ELISA); at baseline and 3 months post treatment. Results: Both, control and test sites, demonstrated improvement in the clinical parameters and reduction in GCF MMP-9 levels during the study period. Test sites exhibited a statistically significant reduction (P <0.05) in PD and RAL (gain in clinical attachment level; CAL) and GCF MMP-9 levels than the control sites. All the clinical parameters showed a positive correlation with the GCF MMP-9 levels. Conclusion: Within the limitations of this study, 4% MG gel proves to be an efficacious adjunctive agent to SRP, for management of chronic periodontitis.

Keywords

References

  1. Reference1 Aljuanid MA, Qaid HR, Lashari DM, Ridwan RD, Budi HS, Alkadasi BA, et al. Nano-emulsion of mangosteen rind extract in a mucoadhesive patch for periodontitis regenerative treatment: An in vivo study. J Taibah Univ Med Sci. 2022;17(5):910-20.
  2. Reference2 Bildt MM, Bloemen M, Kuijpers-Jagtman AM, Von den Hoff JW. Collagenolytic fragments and active gelatinase complexes in periodontitis. J Periodontol. 2008;79(9):1704-11.
  3. Reference3 Bural C, Güven MÇ, Kayacıoğlu B, Ak G, Bayraktar G, Bilhan H. Effect of Over-the-Counter Topical Agents on Denture-Induced Traumatic Lesions: A Clinical Study. Int J Prosthodont. 2018;31(5):481-4.
  4. Reference4 Checchi V, Maravic T, Bellini P, Generali L, Consolo U, Breschi L, et al. The Role of Matrix Metalloproteinases in Periodontal Disease. Int J Environ Res Public Health. 2020;17(14):4923-36.
  5. Reference5 Chen CM, Hsieh SC, Lin CL, Lin YS, Tsai JP, Hsieh YH. Alpha-Mangostin Suppresses the Metastasis of Human Renal Carcinoma Cells by Targeting MEK/ERK Expression and MMP-9 Transcription Activity. Cell Physiol Biochem. 2017;44(4):1460-70. Reference6 Drisko CH. Non-surgical pocket therapy: pharmacotherapeutics. Ann Periodontol. 1996;1(1):491-566.
  6. Reference7 Franco C, Patricia HR, Timo S, Claudia B, Marcela H. Matrix Metalloproteinases as Regulators of Periodontal Inflammation. Int J Mol Sci. 2017;18(2):440-52.
  7. Reference8 Gonçalves PF, Huang H, McAninley S, Alfant B, Harrison P, Aukhil I, et al. Periodontal treatment reduces matrix metalloproteinase levels in localized aggressive periodontitis. J Periodontol. 2013;84(12):1801-8.
  8. Reference9 Goodson JM, Hogan PE, Dunham SL. Clinical responses following periodontal treatment by local drug delivery. J Periodontol. 1985;56(11 Suppl):81-7.

Details

Primary Language

English

Subjects

Periodontics

Journal Section

Clinical Research

Early Pub Date

December 25, 2023

Publication Date

December 26, 2023

Submission Date

September 8, 2023

Acceptance Date

December 11, 2023

Published in Issue

Year 2023 Volume: 7 Number: 3

APA
Kulkarni, M., Gunjiganur Vemanaradhya, G., & Mg, T. (2023). Evaluation of 4% Mangosteen (MG) Gel as a Local Drug Delivery in adjunct to Scaling and Root planing on Clinical Parameters and GCF MMP-9 levels in Chronic Periodontitis Patients - A Split Mouth Randomized Controlled Trial. European Journal of Research in Dentistry, 7(3), 130-138. https://doi.org/10.29228/erd.57
AMA
1.Kulkarni M, Gunjiganur Vemanaradhya G, Mg T. Evaluation of 4% Mangosteen (MG) Gel as a Local Drug Delivery in adjunct to Scaling and Root planing on Clinical Parameters and GCF MMP-9 levels in Chronic Periodontitis Patients - A Split Mouth Randomized Controlled Trial. Eur. J. res. Dent. (ERD). 2023;7(3):130-138. doi:10.29228/erd.57
Chicago
Kulkarni, Manjiri, Gayathri Gunjiganur Vemanaradhya, and Triveni Mg. 2023. “Evaluation of 4% Mangosteen (MG) Gel As a Local Drug Delivery in Adjunct to Scaling and Root Planing on Clinical Parameters and GCF MMP-9 Levels in Chronic Periodontitis Patients - A Split Mouth Randomized Controlled Trial”. European Journal of Research in Dentistry 7 (3): 130-38. https://doi.org/10.29228/erd.57.
EndNote
Kulkarni M, Gunjiganur Vemanaradhya G, Mg T (December 1, 2023) Evaluation of 4% Mangosteen (MG) Gel as a Local Drug Delivery in adjunct to Scaling and Root planing on Clinical Parameters and GCF MMP-9 levels in Chronic Periodontitis Patients - A Split Mouth Randomized Controlled Trial. European Journal of Research in Dentistry 7 3 130–138.
IEEE
[1]M. Kulkarni, G. Gunjiganur Vemanaradhya, and T. Mg, “Evaluation of 4% Mangosteen (MG) Gel as a Local Drug Delivery in adjunct to Scaling and Root planing on Clinical Parameters and GCF MMP-9 levels in Chronic Periodontitis Patients - A Split Mouth Randomized Controlled Trial”, Eur. J. res. Dent. (ERD), vol. 7, no. 3, pp. 130–138, Dec. 2023, doi: 10.29228/erd.57.
ISNAD
Kulkarni, Manjiri - Gunjiganur Vemanaradhya, Gayathri - Mg, Triveni. “Evaluation of 4% Mangosteen (MG) Gel As a Local Drug Delivery in Adjunct to Scaling and Root Planing on Clinical Parameters and GCF MMP-9 Levels in Chronic Periodontitis Patients - A Split Mouth Randomized Controlled Trial”. European Journal of Research in Dentistry 7/3 (December 1, 2023): 130-138. https://doi.org/10.29228/erd.57.
JAMA
1.Kulkarni M, Gunjiganur Vemanaradhya G, Mg T. Evaluation of 4% Mangosteen (MG) Gel as a Local Drug Delivery in adjunct to Scaling and Root planing on Clinical Parameters and GCF MMP-9 levels in Chronic Periodontitis Patients - A Split Mouth Randomized Controlled Trial. Eur. J. res. Dent. (ERD). 2023;7:130–138.
MLA
Kulkarni, Manjiri, et al. “Evaluation of 4% Mangosteen (MG) Gel As a Local Drug Delivery in Adjunct to Scaling and Root Planing on Clinical Parameters and GCF MMP-9 Levels in Chronic Periodontitis Patients - A Split Mouth Randomized Controlled Trial”. European Journal of Research in Dentistry, vol. 7, no. 3, Dec. 2023, pp. 130-8, doi:10.29228/erd.57.
Vancouver
1.Manjiri Kulkarni, Gayathri Gunjiganur Vemanaradhya, Triveni Mg. Evaluation of 4% Mangosteen (MG) Gel as a Local Drug Delivery in adjunct to Scaling and Root planing on Clinical Parameters and GCF MMP-9 levels in Chronic Periodontitis Patients - A Split Mouth Randomized Controlled Trial. Eur. J. res. Dent. (ERD). 2023 Dec. 1;7(3):130-8. doi:10.29228/erd.57